StonvexLoading…
StonvexStonvexStonvexCore line items from HSCS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-04-30 | Annual 2024 2024-04-30 | Annual 2023 2023-04-30 | Annual 2022 2022-04-30 |
|---|---|---|---|---|
Revenue | $4.35K | $18.60K | $5.15K | $14.37K |
Operating Income | $-8.35M | $-6.31M | $-6.11M | $-4.71M |
Net Income | $-8.77M | $-6.61M | $-6.35M | $-4.83M |
EPS (Diluted) | $-9.34 | $-18.74 | $-80.00 | $-1.45 |
Total Assets | $4.22M | $9.50M | $3.29M | $2.09M |
Total Liabilities | $4.02M | $2.19M | $3.06M | $8.15M |
Cash & Equivalents | $1.10M | $5.81M | $1.66M | $918.26K |
Free Cash Flow OCF − CapEx | $-7.42M | $-6.13M | $-5.79M | $-3.65M |
Shares Outstanding | 1.12M | 676.60K | 101.33K | 3.32M |